Yingjing Li

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Third Affiliated Hospital of Harbin Medical University(Current)

Harbin Medical University

Yingjing Li is an author at Third Affiliated Hospital of Harbin Medical University specializing in liver disease, small interfering ribonucleic acids (sirnas), and gene delivery.

ORCID

Publications per year

2022–2026

Publications

siRNA targeting PD-L1 delivered with attenuated Salmonella enhanced the anti-tumor effect of lenvatinib on mice bearing Hepatocellular carcinoma

Pengfei Chen, Yingjing Li, Pengkun Wei et al. · International Immunopharmacology · 2022 · 17 citations · Full text

Medicine, Oncology, Pharmacology +15

Engineered outer membrane vesicles enhance solid tumour CAR-T cell therapy

Xianjun Li, Xuehan Li, Yingjing Li et al. · Nature Biomedical Engineering · 2026 · 13 citations · Full text

Medicine, Immunology, Oncology +17

Macrophage hitchhiking for systematic suppression in postablative multifocal HCC

Xuehan Li, Yan Zhang, Shun Li et al. · Hepatology · 2024 · 10 citations

Pharmacy, Oncology, Pharmacology +17

1–3 of 3